Motives for reporting adverse drug reactions by patient-reporters in the Netherlands

AimThe aim of this study was to quantify the reasons and opinions of patients who reported adverse drug reactions (ADRs) in the Netherlands to a pharmacovigilance centre.MethodA web-based questionnaire was sent to 1370 patients who had previously reported an ADR to a pharmacovigilance centre. The data were analysed using descriptive statistics, χ2 tests and Spearman’s correlation coefficients.ResultsThe response rate was 76.5% after one reminder. The main reasons for patients to report ADRs were to share their experiences (89% agreed or strongly agreed), the severity of the reaction (86% agreed or strongly agreed to the statement), worries about their own situation (63.2% agreed or strongly agreed) and the fact the ADR was not mentioned in the patient information leaflet (57.6% agreed or strongly agreed). Of the patient-responders, 93.8% shared the opinion that reporting an ADR can prevent harm to other people, 97.9% believed that reporting contributes to research and knowledge, 90.7% stated that they felt responsible for reporting an ADR and 92.5% stated that they will report a possible ADR once again in the future.ConclusionThe main motives for patients to report their ADRs to a pharmacovigilance centre were the severity of the ADR and their need to share experiences. The high level of response to the questionnaire shows that patients are involved when it comes to ADRs and that they are also willing to share their motivations for and opinions about the reporting of ADRs with a pharmacovigilance centre.

[1]  E. Puijenbroek,et al.  Reporting of Adverse Drug Reactions by General Practitioners , 2009, Drug safety.

[2]  F. van Hunsel,et al.  What Motivates Patients to Report an Adverse Drug Reaction? , 2010, The Annals of pharmacotherapy.

[3]  L. de Jong-van den Berg,et al.  Patients’ role in reporting adverse drug reactions , 2004, Expert opinion on drug safety.

[4]  A. Granås,et al.  Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway , 2007, Pharmacoepidemiology and drug safety.

[5]  L. Berg,et al.  Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting , 2002 .

[6]  B Müller-Oerlinghausen,et al.  Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. , 2002, Journal of clinical epidemiology.

[7]  Jon Nicholl,et al.  Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study , 2007, BMC Health Services Research.

[8]  F. van Hunsel,et al.  Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. , 2009, British journal of clinical pharmacology.

[9]  E. Lopez-Gonzalez,et al.  Determinants of Under-Reporting of Adverse Drug Reactions , 2009, Drug safety.

[10]  M. T. Herdeiro,et al.  Influence of Pharmacists’ Attitudes on Adverse Drug Reaction Reporting , 2006, Drug safety.

[11]  Rawlins,et al.  Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. , 1995, British journal of clinical pharmacology.

[12]  L. Rajmil.  Health measurement scales. A practical guide to their development and use, 3rd ed , 2005 .

[13]  L. J. D. Berg,et al.  Adverse Drug Reaction Reporting by Patients in the Netherlands Three Years of Experience , 2008, Drug safety.

[14]  A. Blenkinsopp,et al.  Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. , 2007, British journal of clinical pharmacology.

[15]  J. Foster,et al.  Patient-reporting of side effects may provide an important source of information in clinical practice , 2007, European Journal of Clinical Pharmacology.

[16]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[17]  I. Edwards,et al.  Reasons for Reporting Adverse Drug Reactions—Some Thoughts Based on an International Review , 1997, Pharmacoepidemiology and drug safety.

[18]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[19]  Ethan Basch,et al.  The missing voice of patients in drug-safety reporting. , 2010, The New England journal of medicine.

[20]  Rawlins,et al.  Attitudinal survey of voluntary reporting of adverse drug reactions. , 1999, British journal of clinical pharmacology.

[21]  W. Rascher,et al.  Women encounter ADRs more often than do men , 2008, European Journal of Clinical Pharmacology.

[22]  T. Mjörndal,et al.  Attitudes to reporting adverse drug reactions in northern Sweden , 2000, European Journal of Clinical Pharmacology.

[23]  E. V. van Puijenbroek,et al.  [Direct reporting of side effects by the patient: favourable experience in the first year]. , 2005, Nederlands tijdschrift voor geneeskunde.

[24]  M. T. Herdeiro,et al.  Physicians’ Attitudes and Adverse Drug Reaction Reporting , 2005, Drug safety.

[25]  K. Belton,et al.  Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union , 1997, European Journal of Clinical Pharmacology.

[26]  A. C. Grootheest,et al.  Meldingen van bijwerkingen rechtstreeks door patiënten : gunstige ervaringen van het eerste jaar , 2005 .

[27]  M. Bäckström,et al.  Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden , 2008, European Journal of Clinical Pharmacology.

[28]  D. Streiner,et al.  Health measurement scales , 2008 .

[29]  Ebba Holme Hansen,et al.  Consumer Reporting of Adverse Drug Reactions , 2009, Drug safety.